William A. Haseltine, Contributor

Author's posts

Eyeing A Cure: Stem Cell Treatments For Macular Degeneration

A comprehensive review by the University of Nevada investigated dry age-related macular degeneration and the latest investigational therapeutics for treating the disease.

In-Ear Bioelectronic May Replace Leading Brain-Computer Implants

In the coming years, a new in-ear bioelectronic called SpiralE may be the next step toward seamless brain-computer interfaces.

New Insights Into The Anti-Aging Properties Of Klotho

The Klotho gene has gained increasing attention for its anti-aging properties. A new study finds that the benefits of this circulating hormone extend beyond the brain.

Innovations In Skeletal Regeneration: Bridging The Gap In Bone Health

New artificial implant scaffolding methods may be the next great leap in bone healing medicine.

A Closer Look At Protein-Based Therapies For Dry Macular Degeneration

In Clinical Ophthalmology, a review examined the investigational therapeutics for treating dry age-related macular degeneration, including protein-based therapies.

Gene Therapy Solutions For Age-Related Macular Degeneration

Gene therapy is currently one of the trailblazing treatments for dry age-related macular degeneration under research.

Revolutionizing Rehabilitation: How Exoskeletons Are Restoring Mobility For Neuromuscular Patients

Advances in exoskeleton technologies will soon help those with impeded neuromuscular connections to walk autonomously once again.

Stem Cell Therapies For Retinal Disorders Are A Sight For Sore Eyes

There are at least ten ongoing clinical trials for stem cell therapies in vision loss. We will delve into one of the preclinical studies in this piece.

Organoids Shed Light On COVID-19 Infection During Pregnancy

A recently developed placental organoid offers new insights into the effects of SARS-CoV-2 infection on pregnant women and their children.

Whole Genome Sequencing More Effective Than Targeted Gene Sequencing For Diagnosing Genetic Disorders In Newborns

A new national study has found whole genome sequencing to be nearly twice as effective as a targeted gene sequencing test.